Search Results - "WOLF, Ido"

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation by Cohen, Dan, Krauthammer, Shir Hazut, Wolf, Ido, Even-Sapir, Einat

“…Purpose Nationwide mass vaccination against Covid-19 started in Israel in late 2020. Soon we identified on [ 18 F]FDG PET-CT studies vaccine-associated…”
Get full text

Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion by Kushnir, Igal, Wolf, Ido

“…Nivolumab, a programmed death 1 (PD1) inhibitor, belongs to a family of drugs known as immune checkpoint inhibitors that share a similar toxicity profile,…”
Get more information

Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma by Kuten, Jonathan, Levine, Charles, Shamni, Ofer, Pelles, Sharon, Wolf, Ido, Lahat, Guy, Mishani, Eyal, Even-Sapir, Einat

“…Background [ 18 F]-Fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET/CT) may sometimes be suboptimal for imaging gastric…”
Get full text

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility by Kalich-Philosoph, Lital, Roness, Hadassa, Carmely, Alon, Fishel-Bartal, Michal, Ligumsky, Hagai, Paglin, Shoshana, Wolf, Ido, Kanety, Hannah, Sredni, Benjamin, Meirow, Dror

“…Premature ovarian failure and infertility are major side effects of chemotherapy treatments in young cancer patients. A more thorough understanding of the…”
Get more information

Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis by Barenboim, Alex, Lahat, Guy, Geva, Ravit, Nachmany, Ido, Nakache, Richard, Goykhman, Yaacov, Brazowski, Eli, Rosen, Galia, Isakov, Ofer, Wolf, Ido, Klausner, Joseph M., Lubezky, Nir

“…To assess clinical and pathologic efficacy of neoadjuvant FOLFIRINOX for locally advanced (LAPC) and borderline resectable pancreatic cancer (BRPC). Patients…”
Get full text

Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional study by Asher, Nethanel, Raphael, Ari, Wolf, Ido, Pelles, Sharon, Geva, Ravit

“…Clinical trials are an essential source for advances in oncologic care, yet the enrollment rate is only 2-4%. Patients' reluctance to participate is an…”
Get full text

Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience by Waissengrin, Barliz, MD, Urban, Damien, MD, Leshem, Yasmin, MD, Garty, Meital, BA, Wolf, Ido, MD

“…Abstract Context The use of the cannabis plant ( Cannabis sativa L.) for the palliative treatment of cancer patients has been legalized in multiple…”
Get full text

KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer by ABRAMOVITZ, Lilach, RUBINEK, Tamar, LIGUMSKY, Hagai, BOSE, Shikha, BARSHACK, Iris, AVIVI, Camila, KAUFMAN, Bella, WOLF, Ido

“…Klotho is a transmembrane protein which can be shed, act as a circulating hormone and modulate the insulin-like growth factor (IGF)-I and the fibroblast growth…”
Get full text

The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer by Bar, Yael, Bar, Kfir, Feldman, Didi, Dror, Judith Ben, Shahoha, Meishar, Lerner, Shir, Shachar, Shlomit Strulov, Weiss-Meilik, Ahuva, Dershowitz, Nachum, Wolf, Ido, Sonnenblick, Amir

“…Early invasive ductal carcinoma (IDC) breast cancer often presents with a coexisting ductal carcinoma in situ (DCIS) component, while about 5 % of cases…”
Get full text

R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers by Boldes, Tomer, Merenbakh-Lamin, Keren, Journo, Shani, Shachar, Eliya, Lipson, Doron, Yeheskel, Adva, Pasmanik-Chor, Metsada, Rubinek, Tami, Wolf, Ido

“…Estrogen receptor α (ESR1) plays a critical role in promoting growth of various cancers. Yet, its role in the development of pancreatic cancer is not…”
Get full text

Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen by Brezis, Miriam R, Shachar, Eliya, Peleg Hasson, Shira, Laskov, Ido, Michaan, Nadav, Levy, Bar, Wolf, Ido, Safra, Tamar

“…To evaluate the effectiveness and safety of standard chemotherapy administered to patients >70 years with advanced ovarian cancer (OC). Medical records of 956…”
Get full text

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study by Keizman, Daniel, Frenkel, Moshe, Peer, Avivit, Rosenbaum, Eli, Sarid, David, Leibovitch, Ilan, Mano, Roy, Yossepowitch, Ofer, Wolf, Ido, Geva, Ravit, Margel, David, Rouvinov, Keren, Stern, Anat, Dresler, Hadas, Kushnir, Igal, Eliaz, Isaac

“…The optimal therapy for patients with non-metastatic biochemically relapsed prostate cancer (BRPC-M0) after local therapy is elusive. Thus, the evaluation of…”
Get full text

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study by Keizman, Daniel, Frenkel, Moshe, Peer, Avivit, Kushnir, Igal, Rosenbaum, Eli, Sarid, David, Leibovitch, Ilan, Mano, Roy, Yossepowitch, Ofer, Margel, David, Wolf, Ido, Geva, Ravit, Dresler, Hadas, Rouvinov, Keren, Rapoport, Noa, Eliaz, Isaac

“…Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus pectin (PectaSol , P-MCP), a…”
Get full text

Epigenetic silencing of the tumor suppressor klotho in human breast cancer by Rubinek, Tami, Shulman, Michal, Israeli, Shira, Bose, Shikha, Avraham, Ayelet, Zundelevich, Adi, Evron, Ella, Nili Gal-Yam, Einav, Kaufman, Bella, Wolf, Ido

“…Klotho is a single pass transmembrane protein, associated with premature aging. We identified tumor suppressor activities for klotho, associated with reduced…”
Get full text

Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy by Bar, Jair, Leibowitz, Raya, Reinmuth, Niels, Ammendola, Astrid, Jacob, Eyal, Moskovitz, Mor, Levy-Barda, Adva, Lotem, Michal, Katsenelson, Rivka, Agbarya, Abed, Abu-Amna, Mahmoud, Gottfried, Maya, Harkovsky, Tatiana, Wolf, Ido, Tepper, Ella, Loewenthal, Gil, Yellin, Ben, Brody, Yehuda, Dahan, Nili, Yanko, Maya, Lahav, Coren, Harel, Michal, Raveh Shoval, Shani, Elon, Yehonatan, Sela, Itamar, Dicker, Adam P, Shaked, Yuval

“…Immune checkpoint inhibitors have made a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). However, clinical response varies widely and…”
Get full text

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer by WOLF, Ido, O'KELLY, James, RUBINEK, Tamar, MIN TONG, NGUYEN, Anh, LIN, Bryan T, TAI, Hsin-Hsiung, KARLAN, Beth Y, KOEFFLER, H. Phillip

“…Prostaglandin E(2) plays a growth-stimulatory role in breast cancer, and the rate-limiting enzyme in its synthesis, cyclooxygenase-2, is often overexpressed in…”
Get full text

The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer by Bar, Yael, Bar, Kfir, Itzhak, Itay, Niselbaum, Chen Shitrit, Dershowitz, Nachum, Shachar, Eliya, Weiss-Meilik, Ahuva, Golan, Orit, Wolf, Ido, Menes, Tehillah, Sonnenblick, Amir

“…Symptomatic breast cancers share aggressive clinico-pathological characteristics compared to screen-detected breast cancers. We assessed the association…”
Get full text

The aging suppressor klotho: a potential regulator of growth hormone secretion by Shahmoon, Shiri, Rubinfeld, Hadara, Wolf, Ido, Cohen, Zvi R, Hadani, Moshe, Shimon, Ilan, Rubinek, Tami

“…Klotho is a transmembranal protein highly expressed in the kidneys, choroid plexus, and anterior pituitary. Klotho can also be cleaved and shed and acts as a…”
Get more information

Kambô-Induced Systemic Inflammatory Response: A Case Report of Acute Disease Progression of Cholangiocarcinoma by Peleg Hasson, Shira, Shachar, Eliya, Kessner, Rivka, Shpigel, Shulim, Wolf, Ido

“…Kambô is a cleansing ritual involving the application of a toxin produced by the giant leaf frog (Phyllomedusa bicolor). The Kambô ritual has increasingly been…”
Get full text

Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors by Perelman, Moran Gvili, Brzezinski, Rafael Y, Waissengrin, Barliz, Leshem, Yasmin, Bainhoren, Or, Rubinstein, Tammi Arbel, Perelman, Maxim, Rozenbaum, Zach, Havakuk, Ofer, Topilsky, Yan, Banai, Shmuel, Wolf, Ido, Laufer-Perl, Michal

“…Immune checkpoint inhibitors (ICIs) have revolutionized the prognosis of cancer. Diabetes mellitus (DM) has been shown to have a negative effect on patients…”
Get full text